Luckily, for those unlucky few who suffer from prostate cancer, the FDA has approved a new treatment. It's a "chemotherapy drug Jevtana (cabazitaxel), developed by Sanofi-aventis, for use in combination with the steroid prednisone to treat men with prostate cancer." Jevtana was tested in a wide case study, and it proved to increase the life span of men more than other drugs like mitoxantrone. As with most other drugs, the newly released Jevtana does have side effects that include, "neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, and renal failure."
[Source: http://www.pharmacist.com/AM/Template.cfm?Section=Pharmacy_News&template=/CM/ContentDisplay.cfm&ContentID=23628]
No comments:
Post a Comment